<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this paper we considered different models concerning the clinical expression of neuropsychiatric involvement in course of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>These models describe pathological conditions as multifocal cerebropathy, <z:e sem="disease" ids="C0026976" disease_type="Disease or Syndrome" abbrv="">transverse myelitis</z:e>, <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> and <z:e sem="disease" ids="C0086769" disease_type="Mental or Behavioral Dysfunction" abbrv="">panic attacks</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We have chosen these cases as clinical example of different pathogenic mechanisms responsible of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, as hypercoagulation due to <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, immune-complex <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, complement-mediated autoantibody damage and antibody-induced cytotoxicity </plain></SENT>
<SENT sid="3" pm="."><plain>The prevalence of neuropsychiatric manifestations in 122 SLE patients is also reported </plain></SENT>
<SENT sid="4" pm="."><plain>Finally, the paper reports some guidelines about diagnostic and therapeutic behaviour in course of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
</text></document>